ZENTARIS GMBH
Patent Owner
Stats
- 12 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Jan 20, 2015 most recent publication
Details
- 12 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 899 Total Citation Count
- Sep 25, 1990 Earliest Filing
- 54 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
8669091 Microorganisms as carriers of nucleotide sequences coding for antigens and protein toxins, process of manufacturing and uses thereofNov 13, 07Mar 11, 14[A61K, A01N, C12N]
7884071 Administration form for pharmaceutically active peptides with sustained release and method for the production thereofSep 26, 03Feb 08, 11[A61K, C07K]
7829724 Triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptorsAug 11, 06Nov 09, 10[A61K, A01N, C07D]
7795385 Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorderDec 13, 05Sep 14, 10[A61K]
7732412 Methods of treatment using novel LHRH antagonists having improved solubility propertiesJul 24, 06Jun 08, 10[A61K]
5773032 Long-acting injection suspensions and a process for their preparationJun 10, 96Jun 30, 98[A61K]
5663145 Products for administering an initial high dose of Cetrorelix and producing a combination package for use when treating diseasesDec 08, 94Sep 02, 97[A61K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2012/0252,760 NOVEL PYRIDOPYRAZINES AND THEIR USE AS MODULATORS OF KINASESAbandonedJun 15, 12Oct 04, 12[A61K, C07F, C07D, A61P]
7871977 Process for producing sterile suspensions of slightly soluble basic peptide complexes, sterile suspensions of slightly soluble basic peptide complexes, pharmaceutical formulations containing them, and the use thereof as medicamentsExpiredDec 16, 05Jan 18, 11[A61K, A01N]
2009/0208,461 RECOMBINANT BACTERIA WITH E.COLI HEMOLYSIN SECRETION SYSTEM AND INCREASED EXPRESSION AND/OR SECRETION OF HLYA, PROCESS OF MANUFACTURING AND USES THEREOFAbandonedFeb 05, 09Aug 20, 09[A61K, C12N]
2008/0113,991 Pyridopyrazines and the use thereof as kinase inhibitorsAbandonedNov 12, 07May 15, 08[A61K]
7211588 N-substituted indolyl-3-glyoxylamides, their use as medicaments and process for their preparationExpiredJul 15, 04May 01, 07[A61K]
2007/0010,548 Compounds having inhibitive activity of phosphatidylinositol 3-kinase and methods of use thereofAbandonedJun 14, 04Jan 11, 07[A61K, C12Q, C07D]
7087214 Water-soluble porphyrin platinum compounds with high tumor selectivity and their use for the treatment of benign and malignant tumor diseasesExpiredJan 27, 03Aug 08, 06[A61B]
2006/0105,423 Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumorsAbandonedFeb 13, 03May 18, 06[C07H, C12P, C12N, C07K]
2005/0267,303 Cyclic indole and heteroindole derivatives and methods for making and using as pharmaceuticalsAbandonedMay 24, 05Dec 01, 05[C07D]
2005/0245,523 Heteroaryl derivatives and their use as medicamentsAbandonedJun 14, 05Nov 03, 05[A61K, C07D]
2005/0220,809 Nucleotide sequence coding for a tolc and a defined amino acid sequenceAbandonedMar 30, 05Oct 06, 05[C07H, A61K, C12N, G01N, C07K]
6936615 Heteroaryl derivatives and their use as medicamentsExpiredDec 19, 03Aug 30, 05[A61K, C07D, A61P]
6903080 Disease treatment with novel phospholipid derivativesExpiredNov 08, 02Jun 07, 05[A61K, A61P]
6890926 Heteroaryl derivatives and their use as medicamentsExpiredJul 20, 01May 10, 05[A61K, C07D, A61P]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.